Global game changer in predicting diseases caused by viruses and bacteria affecting plants, animals and humans.
metaBIX Biotech has raised $1.3M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
metaBIX Biotech's investors include EWA Capital, Dalus Capital, AngelHub VC, AIR Capital, Danta Fund.
metaBIX Biotech is headquartered in Montevideo, Uruguay.
Global game changer in predicting diseases caused by viruses and bacteria affecting plants, animals and humans.
metaBIX Biotech is at the Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"metaBIX Biotech — Funding & Investors." VCBacked, March 9, 2026, https://www.vcbacked.co/company/metabix-biotech. Accessed September 30, 2026.
VCBacked. (2026). metaBIX Biotech — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/metabix-biotech
{{cite web |title=metaBIX Biotech — Funding & Investors |url=https://www.vcbacked.co/company/metabix-biotech |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated